Researchers identified new indicators for HER2+ breast cancer response to therapy
Being able to predict the response of cancer to treatment by analyzing a tumor sample before therapy is given would significantly affect clinical outcomes
Read More
Using proteogenomics to improve the treatment of squamous cell carcinoma
Integrating proteogenomics data of squamous cell carcinoma provides insights into genomic defects with implications for potential treatments.
Read More
An unprecedented look at endometrial cancer
Which therapy will benefit this particular patient the most? Dr. Bing Zhang and his colleagues offer insights that might help physicians better answer this question
Read More
Scientists get up close and personal with breast cancer
“Patients die from cancer because, at a sufficiently fundamental level, we have not been able to work out what kind of cancer we are treating,”
Read More
A comprehensive view of colon cancer opens new avenues for research
Analyzing both the entire set of genes and all the proteins produced by colon cancer tissues from patient samples has revealed a more comprehensive view
Read More
An integrated approach to finding new treatments for breast cancer
Unraveling the complexity of cancer biology can lead to the identification new molecules involved in breast cancer and prompt new avenues for drug development. And
Read More
Mutated genes and rogue proteins can reveal new ways to treat breast cancer
Scientists are puzzled by mysteries such as, why a certain drug that induced one tumor to shrink in one patient did not affect the growth
Read More